IBHC VS CALA Stock Comparison

PerformanceTechnicalsVolatilityForecastSentimentEarningsProfitDividend
PerformanceTechnicalsVolatilityForecastSentimentEarningsProfitDividend

Performance

IBHC
10/100

IBHC returned 0.85% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

CALA
10/100

CALA returned -96.80% in the last 12 months. Based on the other stocks in it's sector with an average return of -9.81%, it's performance is below average giving it a grade of 10 of 100.

Technicals

IBHC
86/100

IBHC receives a 85 of 100 based on 14 indicators. 11 are bullish, 1 are bearish.

CALA
11/100

CALA receieves a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Volatility

IBHC
41/100

IBHC has had a lower than average amount of volatility over the last 12 months giving it a score of 41 of 100.

CALA
52/100

CALA has had a higher than average amount of volatility over the last 12 months giving it a grade of 52 of 100.

Forecast

IBHC

"Forecast" not found for IBHC

CALA
81/100

4 analysts offer 12-month price forecasts for CALA. Together, they have an average target of 2, the most optimistic forecast put CALA at 2 within 12-months and the most pessimistic has CALA at 2.

Sentiment

IBHC

"Sentiment" not found for IBHC

CALA
10/100

CALA does not have any recent conclusive social sentiment.

Earnings

IBHC

"Earnings" not found for IBHC

CALA
10/100

CALA has missed earnings 9 times in the last 20 quarters.

Profit

IBHC

"Profit" not found for IBHC

CALA
10/100

Out of the last 20 quarters, CALA has had 2 profitable quarters and has increased their profits year over year on 1 of them.

Dividend

IBHC

"Dividend" not found for IBHC

CALA
10/100

CALA has not paid a dividend in the last 5 years.

All score calculations are broken down here to help you make more informed investing decisions

iShares iBonds 2023 Term High Yield and Income ETF Summary

The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The underlying index is composed of U.S. dollar-denominated, taxable, fixed-rate, high yield and BBB or equivalently rated corporate bonds scheduled to mature between January 1, 2023 and December 15, 2023, inclusive.

Calithera Biosciences, Inc Summary

Nasdaq / CALA